United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors
Tempus Announces Collaboration with United Therapeutics to Study Use of AI to Detect Patients at Risk for Pulmonary Hypertension
United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
United Therapeutics Corporation Reports First Quarter 2024 Financial Results
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024
United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
Novartis is “actively” managing its existing relationships with Chinese service providers to mitigate risks if the Biosecure Act passes.
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
United Therapeutics the First Comprehensive Review Publication
FDA approves Johnson & Johnson`s combo pill Opsynvi for PAH